Radiotherapy for cervical cancer - Multi-institute retrospective analysis

H. Ito, H. Yoshida, Y. Kikuchi, M. Hareyama, Y. Kaneyasu, Naoyuki Shigematsu, T. Nakano, E. Kato, M. Chatani, Y. Takekawa, T. Toita

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Radiotherapy has long been recognized as a successful treatment modality for all stages of carcinoma of the uterine cervix. Patients present first at gynecologic clinics, and it is gynecologists in most institutions who determine the treatment modality without additional inputs of radiotherapists. Most gynecologists consider that surgical treatment is superior to radiotherapy, and, as a result, the majority of patients with stage 0-IIb become subjected to modified or radical hysterectomy and lymphadenectomy. Radiotherapists have to mostly treat the patients with far advanced cancer. Periodic check-ups for uterine cancer have become a very common practice for women over the age 30 years. As a result, the incidence of patients with early stages of cervical cancer subjected to surgery has increased, and that with advanced diseases significantly decreased in recent 10 years. Patients who have cervical cancer and visit radiotherapy department decreased to about 1/3, compared to 15 years ago. In 1983, the standard treatment method of cervical cancer with Co-60 RALS was proposed by Arai et al in Japan. Most institutes accepted this method with some modifications. JASTRO organized the study group to reconsider the treatment modality proposed by Arai et al and reviewed the outcomes from 9 major institutes in Japan. The treatment results of stages I and IVA were different in each institute in spite of applying the similar treatment modality. There was large difference of tumor sizes in stage IIIB. Arai et al suggested that stage IIIB must be subclassified into 3 groups according to tumor volumes, those were small, medium and large. The study group certified this subclassification was very useful to compare the treatment results of stage IIIB. Furthermore, the study group suggests that the more objective tumor measurement is necessary to compare the treatment results in a multiinstitutional study. As for stage IV, some institutes introduced CT and/or MR imaging to evaluate invasion to the rectum or the bladder, and reported good results. The study group found that the clinical staging system was so confused in Japan and suggested that the definition of the clinical staging system must be reconfirmed.

Original languageEnglish
Pages (from-to)177-185
Number of pages9
JournalJournal of JASTRO
Volume12
Issue number2
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Uterine Cervical Neoplasms
Radiotherapy
Japan
Therapeutics
Neoplasms
Uterine Neoplasms
Tumor Burden
Lymph Node Excision
Hysterectomy
Rectum
Cervix Uteri
Urinary Bladder
Carcinoma
Incidence

Keywords

  • Cervical cancer
  • External irradiation
  • Intracavitary brachytherapy
  • Radiotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Radiology Nuclear Medicine and imaging

Cite this

Ito, H., Yoshida, H., Kikuchi, Y., Hareyama, M., Kaneyasu, Y., Shigematsu, N., ... Toita, T. (2000). Radiotherapy for cervical cancer - Multi-institute retrospective analysis. Journal of JASTRO, 12(2), 177-185.

Radiotherapy for cervical cancer - Multi-institute retrospective analysis. / Ito, H.; Yoshida, H.; Kikuchi, Y.; Hareyama, M.; Kaneyasu, Y.; Shigematsu, Naoyuki; Nakano, T.; Kato, E.; Chatani, M.; Takekawa, Y.; Toita, T.

In: Journal of JASTRO, Vol. 12, No. 2, 2000, p. 177-185.

Research output: Contribution to journalArticle

Ito, H, Yoshida, H, Kikuchi, Y, Hareyama, M, Kaneyasu, Y, Shigematsu, N, Nakano, T, Kato, E, Chatani, M, Takekawa, Y & Toita, T 2000, 'Radiotherapy for cervical cancer - Multi-institute retrospective analysis', Journal of JASTRO, vol. 12, no. 2, pp. 177-185.
Ito H, Yoshida H, Kikuchi Y, Hareyama M, Kaneyasu Y, Shigematsu N et al. Radiotherapy for cervical cancer - Multi-institute retrospective analysis. Journal of JASTRO. 2000;12(2):177-185.
Ito, H. ; Yoshida, H. ; Kikuchi, Y. ; Hareyama, M. ; Kaneyasu, Y. ; Shigematsu, Naoyuki ; Nakano, T. ; Kato, E. ; Chatani, M. ; Takekawa, Y. ; Toita, T. / Radiotherapy for cervical cancer - Multi-institute retrospective analysis. In: Journal of JASTRO. 2000 ; Vol. 12, No. 2. pp. 177-185.
@article{23a9773241a54582bb276396dcdd3a3b,
title = "Radiotherapy for cervical cancer - Multi-institute retrospective analysis",
abstract = "Radiotherapy has long been recognized as a successful treatment modality for all stages of carcinoma of the uterine cervix. Patients present first at gynecologic clinics, and it is gynecologists in most institutions who determine the treatment modality without additional inputs of radiotherapists. Most gynecologists consider that surgical treatment is superior to radiotherapy, and, as a result, the majority of patients with stage 0-IIb become subjected to modified or radical hysterectomy and lymphadenectomy. Radiotherapists have to mostly treat the patients with far advanced cancer. Periodic check-ups for uterine cancer have become a very common practice for women over the age 30 years. As a result, the incidence of patients with early stages of cervical cancer subjected to surgery has increased, and that with advanced diseases significantly decreased in recent 10 years. Patients who have cervical cancer and visit radiotherapy department decreased to about 1/3, compared to 15 years ago. In 1983, the standard treatment method of cervical cancer with Co-60 RALS was proposed by Arai et al in Japan. Most institutes accepted this method with some modifications. JASTRO organized the study group to reconsider the treatment modality proposed by Arai et al and reviewed the outcomes from 9 major institutes in Japan. The treatment results of stages I and IVA were different in each institute in spite of applying the similar treatment modality. There was large difference of tumor sizes in stage IIIB. Arai et al suggested that stage IIIB must be subclassified into 3 groups according to tumor volumes, those were small, medium and large. The study group certified this subclassification was very useful to compare the treatment results of stage IIIB. Furthermore, the study group suggests that the more objective tumor measurement is necessary to compare the treatment results in a multiinstitutional study. As for stage IV, some institutes introduced CT and/or MR imaging to evaluate invasion to the rectum or the bladder, and reported good results. The study group found that the clinical staging system was so confused in Japan and suggested that the definition of the clinical staging system must be reconfirmed.",
keywords = "Cervical cancer, External irradiation, Intracavitary brachytherapy, Radiotherapy",
author = "H. Ito and H. Yoshida and Y. Kikuchi and M. Hareyama and Y. Kaneyasu and Naoyuki Shigematsu and T. Nakano and E. Kato and M. Chatani and Y. Takekawa and T. Toita",
year = "2000",
language = "English",
volume = "12",
pages = "177--185",
journal = "Journal of JASTRO",
issn = "1040-9564",
publisher = "Editorial Board of JASTRO",
number = "2",

}

TY - JOUR

T1 - Radiotherapy for cervical cancer - Multi-institute retrospective analysis

AU - Ito, H.

AU - Yoshida, H.

AU - Kikuchi, Y.

AU - Hareyama, M.

AU - Kaneyasu, Y.

AU - Shigematsu, Naoyuki

AU - Nakano, T.

AU - Kato, E.

AU - Chatani, M.

AU - Takekawa, Y.

AU - Toita, T.

PY - 2000

Y1 - 2000

N2 - Radiotherapy has long been recognized as a successful treatment modality for all stages of carcinoma of the uterine cervix. Patients present first at gynecologic clinics, and it is gynecologists in most institutions who determine the treatment modality without additional inputs of radiotherapists. Most gynecologists consider that surgical treatment is superior to radiotherapy, and, as a result, the majority of patients with stage 0-IIb become subjected to modified or radical hysterectomy and lymphadenectomy. Radiotherapists have to mostly treat the patients with far advanced cancer. Periodic check-ups for uterine cancer have become a very common practice for women over the age 30 years. As a result, the incidence of patients with early stages of cervical cancer subjected to surgery has increased, and that with advanced diseases significantly decreased in recent 10 years. Patients who have cervical cancer and visit radiotherapy department decreased to about 1/3, compared to 15 years ago. In 1983, the standard treatment method of cervical cancer with Co-60 RALS was proposed by Arai et al in Japan. Most institutes accepted this method with some modifications. JASTRO organized the study group to reconsider the treatment modality proposed by Arai et al and reviewed the outcomes from 9 major institutes in Japan. The treatment results of stages I and IVA were different in each institute in spite of applying the similar treatment modality. There was large difference of tumor sizes in stage IIIB. Arai et al suggested that stage IIIB must be subclassified into 3 groups according to tumor volumes, those were small, medium and large. The study group certified this subclassification was very useful to compare the treatment results of stage IIIB. Furthermore, the study group suggests that the more objective tumor measurement is necessary to compare the treatment results in a multiinstitutional study. As for stage IV, some institutes introduced CT and/or MR imaging to evaluate invasion to the rectum or the bladder, and reported good results. The study group found that the clinical staging system was so confused in Japan and suggested that the definition of the clinical staging system must be reconfirmed.

AB - Radiotherapy has long been recognized as a successful treatment modality for all stages of carcinoma of the uterine cervix. Patients present first at gynecologic clinics, and it is gynecologists in most institutions who determine the treatment modality without additional inputs of radiotherapists. Most gynecologists consider that surgical treatment is superior to radiotherapy, and, as a result, the majority of patients with stage 0-IIb become subjected to modified or radical hysterectomy and lymphadenectomy. Radiotherapists have to mostly treat the patients with far advanced cancer. Periodic check-ups for uterine cancer have become a very common practice for women over the age 30 years. As a result, the incidence of patients with early stages of cervical cancer subjected to surgery has increased, and that with advanced diseases significantly decreased in recent 10 years. Patients who have cervical cancer and visit radiotherapy department decreased to about 1/3, compared to 15 years ago. In 1983, the standard treatment method of cervical cancer with Co-60 RALS was proposed by Arai et al in Japan. Most institutes accepted this method with some modifications. JASTRO organized the study group to reconsider the treatment modality proposed by Arai et al and reviewed the outcomes from 9 major institutes in Japan. The treatment results of stages I and IVA were different in each institute in spite of applying the similar treatment modality. There was large difference of tumor sizes in stage IIIB. Arai et al suggested that stage IIIB must be subclassified into 3 groups according to tumor volumes, those were small, medium and large. The study group certified this subclassification was very useful to compare the treatment results of stage IIIB. Furthermore, the study group suggests that the more objective tumor measurement is necessary to compare the treatment results in a multiinstitutional study. As for stage IV, some institutes introduced CT and/or MR imaging to evaluate invasion to the rectum or the bladder, and reported good results. The study group found that the clinical staging system was so confused in Japan and suggested that the definition of the clinical staging system must be reconfirmed.

KW - Cervical cancer

KW - External irradiation

KW - Intracavitary brachytherapy

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0033931759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033931759&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033931759

VL - 12

SP - 177

EP - 185

JO - Journal of JASTRO

JF - Journal of JASTRO

SN - 1040-9564

IS - 2

ER -